Tsur Lilach, Kozer Eran, Berkovitch Matitiahu
Clinical Pharmacology Unit, Drug Consultation Center, Assaf Harofeh Medical Center, Zerifin 70300, Israel.
J Womens Health (Larchmt). 2008 May;17(4):579-84. doi: 10.1089/jwh.2007.0623.
Women of reproductive age treated with isotretinoin are required to use two forms of contraceptives, yet adherence to the recommendations is limited. Our objective was to determine if an active intervention by a drug consultation center (DCC) will increase contraceptive use among women taking isotretinoin.
In a randomized, controlled study, women of reproductive age who called the DCC seeking advice regarding isotretinoin were randomly assigned to an intervention group (information by phone during initial interview, by mailed written form, and by text messages sent to their cellular phones) and a control group (information given once). A follow-up call was made to all women 3 months after the first interview.
One hundred eight women (50 in the intervention group and 58 control) were enrolled. Most women do not adhere to the recommended contraceptive use. After 3 months, 50% of the study group and 40% of the control group were using a contraceptive (p = 0.41), and only 2 women in each group used two methods of contraception.
Strategies to increase adherence to contraceptive use among women treated with isotretinoin are needed.
接受异维A酸治疗的育龄妇女需要采用两种避孕方式,但对这些建议的依从性有限。我们的目标是确定药物咨询中心(DCC)的积极干预是否会增加服用异维A酸的女性的避孕措施使用情况。
在一项随机对照研究中,致电DCC寻求异维A酸相关建议的育龄妇女被随机分配到干预组(在初次面谈时通过电话、邮寄书面形式以及发送到其手机的短信提供信息)和对照组(仅提供一次信息)。在首次面谈3个月后对所有女性进行随访电话。
共纳入108名女性(干预组50名,对照组58名)。大多数女性未遵守推荐的避孕措施使用方法。3个月后,研究组50%的女性和对照组40%的女性在使用避孕措施(p = 0.41),每组只有2名女性采用两种避孕方法。
需要采取策略来提高接受异维A酸治疗的女性对避孕措施使用的依从性。